Edition:
United States

Lonza Group AG (LONN.S)

LONN.S on Virt-X Level 1

323.80CHF
11:31am EDT
Change (% chg)

CHF-4.20 (-1.28%)
Prev Close
CHF328.00
Open
CHF328.00
Day's High
CHF328.50
Day's Low
CHF323.80
Volume
187,795
Avg. Vol
278,998
52-wk High
CHF342.00
52-wk Low
CHF245.10

About

Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life science industries. The Company's offerings include custom development and manufacturing of drugs and drug delivery systems, as well as development of anti-microbial solutions for commercial applications. The... (more)

Overall

Beta: 0.99
Market Cap(Mil.): CHF19,317.19
Shares Outstanding(Mil.): 74.47
Dividend: 2.55
Yield (%): 0.98

Financials

  LONN.S Industry Sector
P/E (TTM): 46.00 69.29 32.55
EPS (TTM): 5.64 -- --
ROI: 5.24 8.90 13.82
ROE: 9.24 10.04 15.24

Lonza carves out Specialty Ingredients business, shares rise

ZURICH Lonza Group will carve out its Specialty Ingredients (LSI) business and cut around 130 jobs there as it reorganizes a division that has struggled, the Swiss group said on Monday.

Jun 03 2019

UPDATE 1-Lonza carves out Specialty Ingredients business, shares rise

ZURICH, June 3 Lonza Group will carve out its Specialty Ingredients (LSI) business and cut around 130 jobs there as it reorganises a division that has struggled, the Swiss group said on Monday.

Jun 03 2019

BRIEF-Carve-out costs for Lonza Specialty Ingredients Won't Affect 2019 Guideline - CEO

* LONZA GROUP CEO SAYS ADDITIONAL COSTS FOR CARVED-OUT SPECIALTY INGREDIENTS BUSINESS WON'T AFFECT 2019 GUIDELINES Source text for Eikon: Further company coverage: (Reporting By Michael Shields)

Jun 03 2019

REFILE-Lonza to carve out Specialty Ingredients business

ZURICH, June 3 Lonza Group will carve out its Specialty Ingredients (LSI) business and cut around 130 jobs there, as it reorganises a division that has struggled this year.

Jun 03 2019

BRIEF-Lonza Group Announced Intention To Proceed With A Carve-Out Of Its Specialty Ingredients Segment (LSI)

* LONZA GROUP AG - INTENTION TO PROCEED WITH A CARVE-OUT OF ITS SPECIALTY INGREDIENTS SEGMENT (LSI)

Jun 03 2019

BRIEF-Lonza says newly aligned specialty ingredients segment performed below expectations in Q1

* OUTLOOK 2019 MAINTAINED AND ACCELERATED PORTFOLIO REVIEW ONGOING

Apr 18 2019

BRIEF-Lonza Group And Chr. Hansen To Establish Joint Venture

* LONZA AND CHR. HANSEN IN JOINT VENTURE TO ACCELERATE MOMENTUM IN MICROBIOME

Apr 02 2019

BRIEF-Lonza Completes Divestment Of Water Care Business

* ANNOUNCED TODAY COMPLETION OF DIVESTMENT OF ITS FORMER WATER CARE BUSINESS AND OPERATIONS TO PLATINUM EQUITY FOR USD 630 MILLION Source text for Eikon: Further company coverage: (Reporting by Berlin Speed Desk)

Mar 01 2019

BRIEF-Lonza Aligns Structure, Creates New Executive Committee Position

* LONZA STRENGTHENS PHARMA, BIOTECH AND NUTRITION OFFERINGS WITH ALIGNED STRUCTURE AND NEW EXECUTIVE COMMITTEE APPOINTMENT

Feb 25 2019

BRIEF-Emerald, Lonza To Manufacture Cannabinoid-Derived Drug Candidate

* EMERALD HEALTH PHARMACEUTICALS AND LONZA ANNOUNCE AGREEMENT FOR MANUFACTURING OF NOVEL CANNABINOID-DERIVED DRUG CANDIDATE

Feb 13 2019

Earnings vs. Estimates